Steven Boyd, 10% Owner at ReShape Lifesciences Inc. (RSLS), sold 4,606,938 shares at $7.13 ($28.5M) on 2021-06-17, disclosed to the SEC on 2021-06-22.
Open-market sale of $28.5M RSLS by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.52 | 388,045 | $2.5M | 8.9% |
| 2 | $6.52 | 388,045 | $2.5M | 8.9% |
| 3 | $7.92 | 73,591 | $583K | 2.0% |
| 4 | $7.92 | 73,591 | $583K | 2.0% |
| 5 | $8.52 | 50,040 | $426K | 1.5% |
| 6 | $8.52 | 50,040 |
| $426K |
| 1.5% |
| 7 | $6.20 | 1,024,844 | $6.4M | 22.3% |
| 8 | $6.20 | 1,024,844 | $6.4M | 22.3% |
| 9 | $7.13 | 81,366 | $580K | 2.0% |
| 10 | $7.13 | 81,366 | $580K | 2.0% |
| 11 | $5.48 | 685,583 | $3.8M | 13.2% |
| 12 | $5.48 | 685,583 | $3.8M | 13.2% |
| Total | $6.18 avg | 4,606,938 | $28.5M | 100% |
| Filing → |
| AVTX | BUY | 2022-01-14 | $451K | — | Filing → |
| CERC | BUY | 2021-08-18 | $194K | — | Filing → |
| EYEG | SELL | 2021-07-29 | $27.9M | — | Filing → |